Outlook Therapeutics Inc

NASDAQ:OTLK   4:00:00 PM EDT
1.15
0.00 (0.00%)
6:56:33 PM EDT: $1.18 +0.03 (+2.61%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Outlook Therapeutics Inc Stock, NASDAQ:OTLK

485 Route 1 South, Building F, Suite 320, Iselin, New Jersey 08830
United States of America
Phone: +1.609.619.3990
Number of Employees: 17

Description

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ.